Although the function of cathepsin L (Ctsl) in the complex process of tumorigenesis is not yet fully understood, the upregulation of its mRNA and protein levels especially in breast cancer correlates with a higher risk of relapse, poor therapy outcome, and worse overall survival [11,12,13]. Here, CTSL is linked to breast cancer.